发明名称 Mc1-1 gene regulatory elements and a pro-apoptotic mc1-1 variant
摘要 The present invention relates to a human Mcl-1 gene, to nucleotide sequences that act as regulatory elements for expression of an Mcl-1 gene, to polynucleotides encoding a variant Mcl-1s/DeltaTM polypeptide, and to oligonucleotides, which contain at least ten nucleotides and can hybridize specifically to a splice junction of the disclosed Mcl-1 gene or to a polynucleotide encoding an Mcl-1 variant polypeptide as disclosed herein. The invention also relates to an Mcl-1s/DeltaTM polypeptide, as well as to antibodies that can interact specifically with an epitope of Mcl-1s/DeltaTM, but not with an epitope of the full length Mcl-1 polypeptide. In addition, the invention relates to a method of expressing a nucleic acid molecule in a cell by introducing into the cell the Mcl-1 gene regulatory element as disclosed herein, such that a nucleic acid molecule that is operatively linked to the Mcl-1 gene regulatory element is expressed in the cell. Additionally, the present invention relates to a method of identifying an agent that can modulate expression of a nucleic acid molecule from an Mcl-1 gene regulatory element. The present invention also relates to methods of modulating apoptosis of a cell, for example, by introducing an Mcl-1 gene regulatory element as disclosed herein into the cell, by introducing into the cell an Mcl-1 gene sequence as disclosed herein, or by expressing the Mcl-1s/DeltaTM polypeptide in the cell. The present invention further relates to a method of identifying a cellular factor that can be involved in splicing of an Mcl-1 gene transcript. In addition, the present invention relates to a method of identifying an agent that induces expression of the Mcl-1s/DeltaTM polypeptide in a cell. The present invention also relates to a method of identifying a cell that expresses an Mcl-1s/DeltaTM polypeptide. The invention further relates to methods of treating a pathologic condition by inducing apoptosis in cells involved in the pathologic condition or by increasing viability of cells involved in the pathologic condition.
申请公布号 US6800750(B1) 申请公布日期 2004.10.05
申请号 US20000483184 申请日期 2000.01.14
申请人 DARTMOUTH COLLEGE;UNIVERSITY OF SHEFFIELD 发明人 CRAIG RUTH W.;BINGLE COLIN D.;WHYTE MOIRA
分类号 C07K14/47;(IPC1-7):C07H21/04;C21N1/19;C21N1/21;C21N5/16;C21N15/63 主分类号 C07K14/47
代理机构 代理人
主权项
地址